Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Total Assets (Quarterly): 1.336B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.336B |
| September 30, 2023 | 1.385B |
| June 30, 2023 | 1.472B |
| March 31, 2023 | 1.516B |
| December 31, 2022 | 1.163B |
| September 30, 2022 | 1.228B |
| June 30, 2022 | 433.56M |
| March 31, 2022 | 474.47M |
| December 31, 2021 | 527.67M |
| September 30, 2021 | 540.10M |
| June 30, 2021 | 577.19M |
| Date | Value |
|---|---|
| March 31, 2021 | 593.26M |
| December 31, 2020 | 347.62M |
| September 30, 2020 | 364.44M |
| June 30, 2020 | 377.82M |
| March 31, 2020 | 389.72M |
| December 31, 2019 | 393.02M |
| September 30, 2019 | 164.23M |
| June 30, 2019 | 79.36M |
| March 31, 2019 | 85.40M |
| December 31, 2018 | 15.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
347.62M
Minimum
Dec 2020
1.516B
Maximum
Mar 2023
771.78M
Average
540.10M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 93.67B |
| RayzeBio inc (DELISTED) | 603.51M |
| Icosavax Inc (DELISTED) | 251.30M |
| Madrigal Pharmaceuticals Inc | 1.073B |
| Theseus Pharmaceuticals Inc (DELISTED) | 234.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 81.97M |
| Shareholders Equity (Quarterly) | 1.254B |